Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.865 EUR -0.52% Intraday chart for PHAXIAM Therapeutics S.A. -3.21% -37.72%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI
ca3fc708011905ac0846c3d64.2L8bF-6bdVCVuasNY8EbZEzQ2YpIRP0lortlIUbAn0g.79xDc6j0HAXl6eRdLbBNJiuqkPgDEotE7egIUw2s-AKbhl8n3PYlMfT6yA~0b1f096cf328144b2b2348ac7fe4143b
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. Charts PHAXIAM Therapeutics S.A.
  5. News Chart